Assessment of Central Sensitization, Neuropathic Pain, Sleep Quality and Daily Life Activities in Behcet's Disease

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

May 22, 2018

Primary Completion Date

February 1, 2019

Study Completion Date

March 21, 2019

Conditions
Behcet's DiseaseCentral Sensitisation
Interventions
DIAGNOSTIC_TEST

Central sensitisation

Central Sensitization Inventory, which is a comprehensive self-report inventory to assess the overlapping symptom dimensions of central sensitisation syndrome will be used to identify participants with central sensitisation.

DIAGNOSTIC_TEST

Neuropathic pain

Frequency of neuropatic pain will be investigated using Pain Detect Questionnaire

OTHER

Sleep disturbance

Assessment of sleep disturbance will be assessed by Pittsburgh Sleep Quality Index

OTHER

Quality of life

Quality of life will be assessed by the Nottingham Health Profile

Trial Locations (1)

16230

Bursa Yüksek İhtisas Education and Research Hospital, Bursa

All Listed Sponsors
lead

Bursa Yuksek Ihtisas Training and Research Hospital

OTHER_GOV

NCT03531385 - Assessment of Central Sensitization, Neuropathic Pain, Sleep Quality and Daily Life Activities in Behcet's Disease | Biotech Hunter | Biotech Hunter